Katrina A Muraglia

Title: Innovations in Cystic Fibrosis Treatment by Katrina A Muraglia

Introduction

Katrina A Muraglia is a prominent inventor based in Champaign, Illinois, known for her significant contributions to the field of cystic fibrosis treatment. With a total of two patents to her name, she has made remarkable strides in developing methods that enhance the quality of life for patients suffering from this genetic disorder.

Latest Patents

Her latest patents include "Genotype-agnostic rescue of cystic fibrosis with small molecule bicarbonate channels." This patent discloses methods of treating cystic fibrosis using amphotericin B (AmB) and a sterol, along with methods for increasing the pH of airway surface liquid in patients and decreasing the viscosity of airway surface liquid. Another notable patent is "Small molecule-mediated restoration of airway surface physiology in human cystic fibrosis lung epithelia," which provides methods of treating cystic fibrosis using AmB or complexes comprising AmB and sterols.

Career Highlights

Katrina has worked with esteemed institutions such as the University of Illinois and the University of Iowa Research Foundation. Her work has focused on innovative approaches to address the challenges faced by cystic fibrosis patients, showcasing her dedication to improving healthcare outcomes.

Collaborations

Throughout her career, Katrina has collaborated with notable individuals in her field, including Martin D Burke and Rajeev S Chorghade. These partnerships have furthered her research and contributed to the advancement of cystic fibrosis treatments.

Conclusion

Katrina A Muraglia's innovative work in the treatment of cystic fibrosis highlights her commitment to medical advancements. Her patents and collaborations reflect her significant impact on the field, making her a key figure in the ongoing fight against this challenging disease.